Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
First Claim
Patent Images
1. 5(R)-Isoxazol-3-yloxymethyl-3-(4-(1-(2(S),3-dihydroxypropanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)-oxazolidin-2-one, or a pharmaceutically-acceptable salt or in vivo-hydrolyzable ester thereof.
2 Assignments
0 Petitions
Accused Products
Abstract
Compounds of formula (I) as defined herein, or a pharmaceutically acceptable salt, or an in-vivo-hydrolysable ester thereof, are useful as antibacterial agents. Processes for their manufacture and pharmaceutical compositions containing them are described.
-
Citations
12 Claims
-
1. 5(R)-Isoxazol-3-yloxymethyl-3-(4-(1-(2(S),3-dihydroxypropanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)-oxazolidin-2-one, or a pharmaceutically-acceptable salt or in vivo-hydrolyzable ester thereof.
-
2. 5(R)-Isoxazol-3-yloxymethyl-3-(4-(1-(2(S)-hydroxy-3-phosphoryl-propanoyl)-1,2,5,6-tetrah dropyrid-4-yl)-3,5-difluorophenyl)oxazolidin-2-one, or a pharmnaceutically-acceptable salt thereof.
-
3. The disodium salt of 5(R)-isoxazol-3-yloxymethyl-3-(4-(1-(2(S)-hydroxy-3-phosphoryl-propanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)oxazolidin-2-one.
-
4. A pharmaceutical composition comprising a pharmaceutically-acceptable diluent or carrier and 5(R)-isoxazol-3-yloxymethyl-3-(4-(1-(2(S),3-dihydroxypropanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)-oxazolidin-2-one, or a pharmaceutically-acceptable salt, or in-vivo hydrolysable ester thereof.
-
5. A pharmaceutical composition comprising a pharmaceutically-acceptable diluent or carrier and 5(R)-isoxazol-3-yloxymethyl-3-(4-(1-(2(S)-hydroxy-3-phosphoryl-propanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)oxazolidin-2-one or a pharmaceutically-acceptable salt thereof.
-
6. A pharmaceutical composition comprising a pharmaceutically-acceptable diluent or carrier and the disodium salt of 5(R)-isoxazol-3-yloxymethyl-3-(4-(1-(2(S)-hydroxy-3-phosphoryl-propanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)oxazolidin-2-one.
-
7. A method for producing an antibacterial effect in a warm blooded animal, comprising administering to the said animal in need thereof an effective amount of the compound 5(R)-isoxazol-3-yloxymethyl-3-(4-(1-(2(S),3-dihydroxypropanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)-oxazolidin-2-one or a pharmaceutically-acceptable salt or in vivo-hydrolyzable ester thereof.
-
8. A method for producing an antibacterial effect in a warm blooded animal, comprising administering to said animal in need thereof an effective amount of the compound 5(R)-isoxazol-3-yloxymethyl-3-(4-(1-(2(S)-hydroxy-3-phosphoryl-propanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)oxazolidin-2-one, or a pharmaceutically-acceptable salt thereof.
-
9. A method for producing an antibacterial effect in a warm blooded animal, comprising administering to said animal in need thereof an effective amount of the disodium salt of 5(R)-isoxazol-3-yloxymethyl-3-(4-(1-(2(S)-hydroxy-3-phosphoryl-propanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)oxazolidin-2-one.
-
10. A method for producing an antibacterial effect in a warm blooded animal, comprising administering to said animal in need thereof an effective amount of a pharmaceutical composition comprising the compound 5(R)-isoxazol-3-yloxymethyl-3-(4-(1-(2(S),3-dihydroxypropanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)-oxazolidin-2-one, or a pharmaceutically-acceptable salt, or in vivo-hydrolyzable ester thereof;
- and a pharmaceutically-acceptable diluent or carrier.
-
11. A method for producing an antibacterial effect in a warm blooded animal, comprising administering to said animal in need thereof an effective amount of a pharmaceutical composition comprising the compound 5(R)-isoxazol-3-yloxymethyl-3-(4-(1-(2(S)-hydroxy-3-phosphoryl-propanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)oxazolidin-2-one or a pharmaceutically-acceptable salt thereof;
- and a pharmaceutically-acceptable diluent or carrier.
-
12. A method for producing an antibacterial effect in a warm blooded animal, comprising administering to said animal in need thereof an effective amount of a pharmaceutical composition comprising the disodium salt of 5(R)-isoxazol-3-yloxymethyl-3-(4-(1-(2(S)-hydroxy-3-phosphoryl-propanoyl)-1,2,5,6-tetrahydropyrid-4-yl)-3,5-difluorophenyl)oxazolidin-2-one;
- and a pharmaceutically-acceptable diluent or carrier.
Specification